POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $624,979 | -26.4% | 93,700 | 0.0% | 0.19% | -28.1% |
| Q2 2023 | $848,922 | -41.2% | 93,700 | -52.8% | 0.26% | -55.9% |
| Q1 2023 | $1,442,928 | -50.6% | 198,477 | -50.5% | 0.60% | -28.7% |
| Q4 2022 | $2,921,919 | +26.0% | 400,812 | +33.6% | 0.84% | +6.6% |
| Q3 2022 | $2,319,000 | +42.2% | 300,000 | +46.6% | 0.78% | +16.1% |
| Q1 2022 | $1,631,000 | +42.4% | 204,679 | +0.1% | 0.68% | +45.5% |
| Q4 2021 | $1,145,000 | +107.4% | 204,462 | +185.0% | 0.46% | +48.7% |
| Q3 2021 | $552,000 | – | 71,729 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,560,984 | $27,526,000 | 6.63% |
| Fairmount Funds Management LLC | 2,833,950 | $21,906,000 | 3.85% |
| JOHNSON & JOHNSON | 1,000,000 | $7,730,000 | 2.28% |
| BVF INC/IL | 5,590,048 | $43,211,000 | 1.78% |
| Affinity Asset Advisors, LLC | 746,576 | $5,771,000 | 1.61% |
| Sio Capital Management, LLC | 544,545 | $4,209,000 | 1.34% |
| PFM Health Sciences, LP | 4,515,216 | $34,903,000 | 1.26% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,052,842 | $8,138,000 | 1.13% |
| Boxer Capital, LLC | 2,500,000 | $19,325,000 | 1.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 300,000 | $2,319,000 | 0.78% |